Search for Clinical Trial Results
Agranulocytosis - 258 Studies Found
Status | Study |
Completed |
Study Name: G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy Condition:
|
Terminated |
Study Name: FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients Condition: Cancer Date: 2008-06-25 Interventions: Procedure: Imaging study (FDG-PET/CT scan) FDG-PET/CT scan-The scans that will be done with a radioactiv |
Terminated |
Study Name: Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations Condition:
Date: 2008-05-05 |
Completed |
Study Name: Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) Condition:
Date: 2008-02-28 Interventions:
|
Completed |
Study Name: Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) Condition: Fungal Infection Date: 2007-10-19 Interventions: Drug: MK0991, caspofungin acetate / Duration of Treatment: |
Terminated |
Study Name: Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics Condition: Febrile Neutropenia Date: 2007-01-08 Interventions:
|
Completed |
Study Name: A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) Condition: Fungal Infection Date: 2006-09-22 Interventions: Drug: caspofungin acetate Cancidas 50 mg dose followed by 70 mg load on day 1 was administered in Indian |
Completed |
Study Name: Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients Condition: Neutropenia Date: 2006-08-14 Interventions: Drug: pegfilgrastim |
Withdrawn |
Study Name: Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy Condition:
|
Completed |
Study Name: Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) Condition: Fungal Infection Date: 2006-02-14 Interventions: Drug: caspofungin acetate (50 mg/m²/day and 70 mg/m²/day) Caspofungin will be given for a mini |